Stocks analysis

Analysis for UNH

$406.67 +11.05 (+2.79%)
  • 📈 Growth — 20/30
  • 💰 Profitability — 18/20
  • 🏦 Financial Health — 17/20
  • 💵 Valuation — 15/20
  • ⚠️ Risk — 6/10
Overall Score: 74/100

Summary:


📈 Growth & Financial Trajectory

Over the eight quarters, revenues rise from about $100.8B in 2024 Q3 to about $112.0B in 2026 Q2, an ~11% gain. Net income fluctuates: ~$6.26B in 2024 Q3, peak ~$6.47B in 2025 Q1, dip to ~$2.18B in 2025 Q4, then rebound to ~$5.67B in 2026 Q2. The path shows top-line resilience with earnings volatility, including a mid-period trough followed by a rebound in early 2026.

💰 Margins & Cash Flow

Gross margins sit in the mid-to-upper 80s%. Operating margins oscillate but stay positive; benefits costs rise, yet profitability remains solid. Net cash flow from operating activities is robust and trends higher into 2026, supporting liquidity, while investing/financing cash flows vary but do not erode operating strength.

🛡️ Balance Sheet & Liquidity

Balance sheet remains asset-rich (~$309–$312B) with Equity around $98–100B and current liabilities ~ $111–$115B. Current ratio sits near 0.8–1.0, signaling manageable liquidity. No material long-term leverage anomaly; cash generation underpins balance-sheet resilience.

⚠️ Key Drivers & Risks

  • Drivers: Scale in managed care operations and cost-management effectiveness; steady premium revenue.
  • Risks: Earnings volatility from benefits costs and regulatory/policy shifts; valuation sensitivity to margin fluctuations.

📊 Key Financial Fundamentals

Valuation Multiples
Market Cap $336.79B
P/E Ratio 23.85
Forward P/E 19.67
P/S Ratio 0.75
P/B Ratio 3.61
EV / EBITDA 14.78
Profitability & Returns
Gross Margin N/A
Operating Margin 4.74%
Net Margin 3.14%
ROE 14.40%
ROIC 8.05%
Financial Health & Liquidity
Current Ratio 0.74
Quick Ratio 0.55
Financial Scale & Cash Flow
Revenue $450.13B
Net Income $14.13B
FCF Yield 7.00%
Free Cash Flow $23.57B
Total Debt To Equity 0.70